Global Macitentan Tablets Market Growth 2024-2030
Description
Global Macitentan Tablets Market Growth 2024-2030
Macitentan is currently the only ERA drug that has conclusive research evidence to support its ability to delay right ventricular remodeling. It is also the only ERA drug that currently has research data to support that a single drug can significantly reduce the risk of patient deterioration or death by 55%.
7. ERA drugs--ERA Drugs--ERA drugs (Endothelin Receptor Antagonists) are a class of drugs used to treat certain cardiovascular and pulmonary diseases. They relax blood vessels, lower blood pressure and improve blood flow by blocking the binding of endothelin, a potent vasoconstrictor, to its receptors.
The global Macitentan Tablets market size is projected to grow from US$ 1967 million in 2024 to US$ 3762 million in 2030; it is expected to grow at a CAGR of 11.4% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Macitentan Tablets Industry Forecast” looks at past sales and reviews total world Macitentan Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Macitentan Tablets sales for 2024 through 2030. With Macitentan Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Macitentan Tablets industry.
This Insight Report provides a comprehensive analysis of the global Macitentan Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Macitentan Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Macitentan Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Macitentan Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Macitentan Tablets.
United States market for Macitentan Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Macitentan Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Macitentan Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Macitentan Tablets players cover Johnson & Johnson, Zhengda Tianqing, Sinotherapeutics, Qilu Pharmaceutical, Hangzhou Zhongmei Huadong Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Macitentan Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Original Drug
Generic Drug
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Zhengda Tianqing
Sinotherapeutics
Qilu Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
Shanghai Xudong Haipu Pharmaceutical
Shanghai Pharmaceutical Group
Jiangsu Yunyang Group Pharmaceutical
Mylan
Teva
Dr. Reddy's Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global Macitentan Tablets market?
What factors are driving Macitentan Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Macitentan Tablets market opportunities vary by end market size?
How does Macitentan Tablets break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
112 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Macitentan Tablets Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Macitentan Tablets by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Macitentan Tablets by Country/Region, 2019, 2023 & 2030
- 2.2 Macitentan Tablets Segment by Type
- 2.2.1 Original Drug
- 2.2.2 Generic Drug
- 2.3 Macitentan Tablets Sales by Type
- 2.3.1 Global Macitentan Tablets Sales Market Share by Type (2019-2024)
- 2.3.2 Global Macitentan Tablets Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Macitentan Tablets Sale Price by Type (2019-2024)
- 2.4 Macitentan Tablets Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Other
- 2.5 Macitentan Tablets Sales by Application
- 2.5.1 Global Macitentan Tablets Sale Market Share by Application (2019-2024)
- 2.5.2 Global Macitentan Tablets Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Macitentan Tablets Sale Price by Application (2019-2024)
- 3 Global by Company
- 3.1 Global Macitentan Tablets Breakdown Data by Company
- 3.1.1 Global Macitentan Tablets Annual Sales by Company (2019-2024)
- 3.1.2 Global Macitentan Tablets Sales Market Share by Company (2019-2024)
- 3.2 Global Macitentan Tablets Annual Revenue by Company (2019-2024)
- 3.2.1 Global Macitentan Tablets Revenue by Company (2019-2024)
- 3.2.2 Global Macitentan Tablets Revenue Market Share by Company (2019-2024)
- 3.3 Global Macitentan Tablets Sale Price by Company
- 3.4 Key Manufacturers Macitentan Tablets Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Macitentan Tablets Product Location Distribution
- 3.4.2 Players Macitentan Tablets Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Market M&A Activity & Strategy
- 4 World Historic Review for Macitentan Tablets by Geographic Region
- 4.1 World Historic Macitentan Tablets Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Macitentan Tablets Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Macitentan Tablets Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Macitentan Tablets Market Size by Country/Region (2019-2024)
- 4.2.1 Global Macitentan Tablets Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Macitentan Tablets Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Macitentan Tablets Sales Growth
- 4.4 APAC Macitentan Tablets Sales Growth
- 4.5 Europe Macitentan Tablets Sales Growth
- 4.6 Middle East & Africa Macitentan Tablets Sales Growth
- 5 Americas
- 5.1 Americas Macitentan Tablets Sales by Country
- 5.1.1 Americas Macitentan Tablets Sales by Country (2019-2024)
- 5.1.2 Americas Macitentan Tablets Revenue by Country (2019-2024)
- 5.2 Americas Macitentan Tablets Sales by Type (2019-2024)
- 5.3 Americas Macitentan Tablets Sales by Application (2019-2024)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Macitentan Tablets Sales by Region
- 6.1.1 APAC Macitentan Tablets Sales by Region (2019-2024)
- 6.1.2 APAC Macitentan Tablets Revenue by Region (2019-2024)
- 6.2 APAC Macitentan Tablets Sales by Type (2019-2024)
- 6.3 APAC Macitentan Tablets Sales by Application (2019-2024)
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Macitentan Tablets by Country
- 7.1.1 Europe Macitentan Tablets Sales by Country (2019-2024)
- 7.1.2 Europe Macitentan Tablets Revenue by Country (2019-2024)
- 7.2 Europe Macitentan Tablets Sales by Type (2019-2024)
- 7.3 Europe Macitentan Tablets Sales by Application (2019-2024)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Macitentan Tablets by Country
- 8.1.1 Middle East & Africa Macitentan Tablets Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Macitentan Tablets Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Macitentan Tablets Sales by Type (2019-2024)
- 8.3 Middle East & Africa Macitentan Tablets Sales by Application (2019-2024)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Macitentan Tablets
- 10.3 Manufacturing Process Analysis of Macitentan Tablets
- 10.4 Industry Chain Structure of Macitentan Tablets
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Macitentan Tablets Distributors
- 11.3 Macitentan Tablets Customer
- 12 World Forecast Review for Macitentan Tablets by Geographic Region
- 12.1 Global Macitentan Tablets Market Size Forecast by Region
- 12.1.1 Global Macitentan Tablets Forecast by Region (2025-2030)
- 12.1.2 Global Macitentan Tablets Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country (2025-2030)
- 12.3 APAC Forecast by Region (2025-2030)
- 12.4 Europe Forecast by Country (2025-2030)
- 12.5 Middle East & Africa Forecast by Country (2025-2030)
- 12.6 Global Macitentan Tablets Forecast by Type (2025-2030)
- 12.7 Global Macitentan Tablets Forecast by Application (2025-2030)
- 13 Key Players Analysis
- 13.1 Johnson & Johnson
- 13.1.1 Johnson & Johnson Company Information
- 13.1.2 Johnson & Johnson Macitentan Tablets Product Portfolios and Specifications
- 13.1.3 Johnson & Johnson Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Johnson & Johnson Main Business Overview
- 13.1.5 Johnson & Johnson Latest Developments
- 13.2 Zhengda Tianqing
- 13.2.1 Zhengda Tianqing Company Information
- 13.2.2 Zhengda Tianqing Macitentan Tablets Product Portfolios and Specifications
- 13.2.3 Zhengda Tianqing Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Zhengda Tianqing Main Business Overview
- 13.2.5 Zhengda Tianqing Latest Developments
- 13.3 Sinotherapeutics
- 13.3.1 Sinotherapeutics Company Information
- 13.3.2 Sinotherapeutics Macitentan Tablets Product Portfolios and Specifications
- 13.3.3 Sinotherapeutics Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Sinotherapeutics Main Business Overview
- 13.3.5 Sinotherapeutics Latest Developments
- 13.4 Qilu Pharmaceutical
- 13.4.1 Qilu Pharmaceutical Company Information
- 13.4.2 Qilu Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
- 13.4.3 Qilu Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Qilu Pharmaceutical Main Business Overview
- 13.4.5 Qilu Pharmaceutical Latest Developments
- 13.5 Hangzhou Zhongmei Huadong Pharmaceutical
- 13.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
- 13.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
- 13.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Main Business Overview
- 13.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Latest Developments
- 13.6 Shanghai Xudong Haipu Pharmaceutical
- 13.6.1 Shanghai Xudong Haipu Pharmaceutical Company Information
- 13.6.2 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
- 13.6.3 Shanghai Xudong Haipu Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Shanghai Xudong Haipu Pharmaceutical Main Business Overview
- 13.6.5 Shanghai Xudong Haipu Pharmaceutical Latest Developments
- 13.7 Shanghai Pharmaceutical Group
- 13.7.1 Shanghai Pharmaceutical Group Company Information
- 13.7.2 Shanghai Pharmaceutical Group Macitentan Tablets Product Portfolios and Specifications
- 13.7.3 Shanghai Pharmaceutical Group Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 Shanghai Pharmaceutical Group Main Business Overview
- 13.7.5 Shanghai Pharmaceutical Group Latest Developments
- 13.8 Jiangsu Yunyang Group Pharmaceutical
- 13.8.1 Jiangsu Yunyang Group Pharmaceutical Company Information
- 13.8.2 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Product Portfolios and Specifications
- 13.8.3 Jiangsu Yunyang Group Pharmaceutical Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Jiangsu Yunyang Group Pharmaceutical Main Business Overview
- 13.8.5 Jiangsu Yunyang Group Pharmaceutical Latest Developments
- 13.9 Mylan
- 13.9.1 Mylan Company Information
- 13.9.2 Mylan Macitentan Tablets Product Portfolios and Specifications
- 13.9.3 Mylan Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Mylan Main Business Overview
- 13.9.5 Mylan Latest Developments
- 13.10 Teva
- 13.10.1 Teva Company Information
- 13.10.2 Teva Macitentan Tablets Product Portfolios and Specifications
- 13.10.3 Teva Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Teva Main Business Overview
- 13.10.5 Teva Latest Developments
- 13.11 Dr. Reddy's Laboratories
- 13.11.1 Dr. Reddy's Laboratories Company Information
- 13.11.2 Dr. Reddy's Laboratories Macitentan Tablets Product Portfolios and Specifications
- 13.11.3 Dr. Reddy's Laboratories Macitentan Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Dr. Reddy's Laboratories Main Business Overview
- 13.11.5 Dr. Reddy's Laboratories Latest Developments
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


